IGEM Therapeutics Appoints Dr David Chiswell as a Non-Executive Chairman
April 9, 2019
Cambridge Antibody Technology co-founder and CEO, Dr Chiswell brings 30 years of biotechnology experience to IGEM’s Board London, 9 April 2019 – IGEM Therapeutics (IGEM),